HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma

HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma

Abstract Hematological and neurological expressed 1 like (HN1L) is a newly identified oncogene in lung cancer and hepatocellular carcinoma recently identified by our team, but its roles in the development and treatment of esophageal squamous cell carcinoma (ESCC) remain incompletely cataloged. Here,...

Full description

Bibliographic Details
Main Authors: Ting-Ting Zeng, Tian-Hao Deng, Zhen Liu, Jia-Rong Zhan, Yuan-Zhen Ma, Yuan-Yuan Yan, Xiao Sun, Ying-Hui Zhu, Yan Li, Xin-Yuan Guan, Lei Li
Format: Article
Language:English
Published: Nature Publishing Group 2022-12-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05478-1

Internet

https://doi.org/10.1038/s41419-022-05478-1

Similar Items